Image classification of experimental yields for cardiomyocyte cells differentiated from human induced pluripotent stem cells
Cardiovascular diseases (CVDs) are the number one cause of death worldwide. Mass
production of engineered heart tissue using differentiation of human-induced pluripotent
stem cells (hiPSCs) can substitute a large number of the lost heart muscle cells in patients
with CVDs. However, the scale-up of the differentiation systems for heart tissue, ie,
cardiomyocyte (CM), production is challenging because many parameters affect the
process. Machine learning (ML) techniques can be employed to identify critical process …
production of engineered heart tissue using differentiation of human-induced pluripotent
stem cells (hiPSCs) can substitute a large number of the lost heart muscle cells in patients
with CVDs. However, the scale-up of the differentiation systems for heart tissue, ie,
cardiomyocyte (CM), production is challenging because many parameters affect the
process. Machine learning (ML) techniques can be employed to identify critical process …